| Title: | Hypopituitarism and cardiovascular risk |
|---|
| Authors: | ID Kraljević, Ivana (Author)
ID Solak, Mirsala (Author)
ID Mandić, Ante (Author)
ID Mlekuš, Katarina (Author)
ID Raičević, Maja (Author)
ID Divanović Slato, Anida (Author)
ID Kovačević, Zlata (Author)
ID Muzurović, Emir (Author) |
|---|
| Files: |  PDF - Presentation file, download (626,41 KB)
MD5: C6F76A65C06F4162AD0BF7F54A930882
 URL - Source URL, visit https://journals.sagepub.com/doi/10.1177/10742484251332398
|
|---|
| Language: | English |
|---|
| Typology: | 1.02 - Review Article |
|---|
| Organization: |  UKC LJ - Ljubljana University Medical Centre
|
|---|
| Abstract: | Hypopituitarism, resulting from a partial or complete deficiency of anterior or posterior pituitary hormones, is associated with increased cardiovascular (CV) morbidity and mortality. This heterogeneous endocrinological disorder may arise from various etiologies, including genetic mutations, pituitary tumors, traumatic brain injury, and autoimmune diseases. Hypopituitarism often results in multiple endocrine deficits that contribute to metabolic dysregulation characterized by insulin resistance, dyslipidemia, and increased visceral adiposity, all known risk factors for CV disease (CVD). Additionally, the presence of chronic inflammation and endothelial dysfunction further increases the risk of CVD in these patients. While standard hormone replacement therapy (HRT) is crucial for restoring hormonal balance, it can sometimes have adverse metabolic effects that can exacerbate atherosclerosis and CVD. Emerging evidence suggests that optimizing HRT regimens and addressing specific hormone deficiencies, such as growth hormone and cortisol, may reduce these risks and improve CV outcomes. This review comprehensively analyzes the etiology, pathophysiological mechanisms underlying CV risk in anterior pituitary dysfunction, and treatment strategies to mitigate CV morbidity and mortality in patients with hypopituitarism. |
|---|
| Keywords: | hypopituitarism, cardiovascular risk, cardiovascular disease, GH deficiency, hormone replacement therapy |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2025 |
|---|
| Number of pages: | str. 1-22 |
|---|
| Numbering: | Vol. 30 |
|---|
| PID: | 20.500.12556/DiRROS-29267  |
|---|
| UDC: | 616.1 |
|---|
| ISSN on article: | 1940-4034 |
|---|
| DOI: | 10.1177/1074248425133239 |
|---|
| COBISS.SI-ID: | 275553027 |
|---|
| Note: |
Nasl. z nasl. zaslona;
Opis vira z dne 17. 4. 2026;
|
|---|
| Publication date in DiRROS: | 05.05.2026 |
|---|
| Views: | 43 |
|---|
| Downloads: | 24 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
